🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a First in Human (FIH) Phase I/II, multinational, multicenter, open...
Status
Completed
Location
O'Neal Comprehensive Cancer Center at UAB
Start Date
2019-12-11
Trial ID
NCT04180215
Treatments Being Tested
MK-8294, the study medicine, is a type of targeted therapy designed to trea...
Status
Recruiting
Location
Northwestern University ( Site 0101)
Start Date
2025-07-23
Trial ID
NCT07030712
The purpose of this study is to evaluate the safety of repeat doses ⁸⁹Zr-Df...
Status
Completed
Location
University of Alabama-Birmingham Hospital
Start Date
2018-12-18
Trial ID
NCT03802123
Treatments Being Tested
A Phase I/IIa First-in-human, Open-label Study to Evaluate the Safety, Phar...
Status
Terminated
Location
Research Site
Start Date
2022-06-07
Trial ID
NCT05397171
Treatments Being Tested
Background: Multiple sclerosis (MS) and progressive multifocal leukoenceph...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2023-10-19
Trial ID
NCT05849467
Treatments Being Tested
This study investigates whether a single subcutaneous administration of ant...
Status
Not Yet Recruiting
Location
Eberhard Karls Universitaet Tuebingen (EKUT)
Start Date
2025-02
Trial ID
NCT06218069
Treatments Being Tested
This is a multi-center, single-arm trial designed to evaluate the safety an...
Status
Recruiting
Location
VUMC
Start Date
2025-03-11
Trial ID
NCT06534190
Treatments Being Tested
The proposed patient study represents the first-ever acute myocarditis pati...
Status
Not Yet Recruiting
Location
University of California, San Francisco
Start Date
2026-08
Trial ID
NCT07481136
The main purpose of this study is to investigate the utility of the new inv...
Status
Withdrawn
Location
Investigational Site - Duarte
Start Date
2019-08
Trial ID
NCT04955262
Treatments Being Tested
This phase I/II trial tests the safety, side effects, and best dose/regimen...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-12-27
Trial ID
NCT07098364